Location History:
- Hillerod, DK (2006)
- Lynge, DK (2003 - 2018)
Company Filing History:
2 out of 3 
2 out of 329 
2 out of 3 Years Active: 2003-2018
Title: Jens Fogh: Innovator in Biopharmaceuticals
Introduction
Jens Fogh is a notable inventor based in Lynge, Denmark. He has made significant contributions to the field of biopharmaceuticals, holding a total of 7 patents. His work primarily focuses on the production and purification of recombinant enzymes, which have important applications in medicine.
Latest Patents
Among his latest patents, Jens Fogh has developed a process for the production and purification of recombinant lysosomal alpha-mannosidase. This invention relates to a method for purifying alpha-mannosidase, a composition that includes this enzyme, and its use as a medicament for treating alpha-mannosidosis. Additionally, he has created an animal model for Krabbe's disease, which serves as a valuable tool for screening and validating potential treatments for globoid cell leukodystrophy.
Career Highlights
Throughout his career, Jens Fogh has worked with prominent companies in the pharmaceutical industry, including Shire Pharmaceuticals Ireland Limited and Chiesi Farmaceutici S.p.a. His expertise in enzyme production and purification has positioned him as a key figure in the development of innovative therapies.
Collaborations
Jens has collaborated with notable professionals in his field, including Claes Andersson and Cecilia Weigelt. These partnerships have further enhanced his research and development efforts.
Conclusion
Jens Fogh's contributions to biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of genetic disorders, showcasing the importance of innovation in medicine.